"Liver Enzymes and Non-Alcoholic Fatty Liver Disease: Important Factors in Assessing Patterns of Clinical Management in Type-2 Diabetes Patients [Letter]." Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, , pp. 777–778
View responses to this article:
Disclosure
The author reports no conflicts of interest for this communication.